You are here

Anaemetro I.V. Infusion 500mg Drug Use Investigation

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Anaerobic Infection, Infectious Enterocolitis, Amebic Dysentery
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients who have not used metronidazole (injection) in the past, and have been given
this drug for treatment of anaerobic infection, infectious enterocolitis, or amebic
dysentery. Patients who have used metronidazole (oral agent and vaginal tablet) in the
past are eligible, and should not be excluded from this study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- No exclusion criteria are set out in this study.

NCT03491228
Pfizer
Completed
Anaemetro I.V. Infusion 500mg Drug Use Investigation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now